Schoels MM, et al. - Researchers assessed the predictive value and clinical use of initial therapeutic response for subsequent achievement of remission and low disease activity during the management of psoriatic arthritis patients (PsA). They noted that 3 months after implementation of therapy in PsA, it was already possible to assess the potential for accomplishing therapeutic goals. This substantiates the choice of the 3-month assessment as essential for treatment adaptations.